The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study.
 
Guillaume Cartron
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Celgene; Mabqi; MedxCell; Roche
Travel, Accommodations, Expenses - Roche
 
Emmanuel Bachy
Honoraria - Amgen; Gilead Sciences; Janssen-Cilag; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Roche; Takeda
Research Funding - Amgen Foundation (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Incyte; Janssen-Cilag; Roche
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
 
Nicolas Daguindau
No Relationships to Disclose
 
Gian Matteo Pica
No Relationships to Disclose
 
Fontanet Bijou
Speakers' Bureau - Abbvie; AstraZeneca
 
Christiane Mounier
No Relationships to Disclose
 
Aline Clavert
Speakers' Bureau - Abbvie; AstraZeneca; Janssen
 
Gandhi Laurent Damaj
Consulting or Advisory Role - Amgen; Blueprint Medicines; iqone; Novartis; Takeda
Research Funding - TAKEDA (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer; Roche/Genentech
 
Borhane Slama
No Relationships to Disclose
 
Olivier Casasnovas
Honoraria - Abbvie; Amgen; BMSi; Gilead Sciences; Janssen; MSD; Roche; Takeda
Consulting or Advisory Role - BMSi; Gilead Sciences; MSD; Roche; Takeda
Research Funding - Gilead Sciences (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; BMSi; Gilead Sciences; Janssen; MSD; Roche; Takeda
 
Roch Houot
Honoraria - BMSi; Celgene; Gilead Sciences; Janssen; Kite, a Gilead Company; MSD; Novartis; Roche
 
Krimo Bouabdallah
Honoraria - Abbvie; Kite/Gilead; Roche; Takeda Science Foundation
Consulting or Advisory Role - Kite/Gilead; Roche; Takeda
Travel, Accommodations, Expenses - Roche; Takeda
 
David Sibon
Consulting or Advisory Role - Abbvie; Iqone healthcare; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Janssen; Takeda
 
Olivier Fitoussi
No Relationships to Disclose
 
Nadine Morineau
No Relationships to Disclose
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
Expert Testimony - Roche/Genentech
 
Luc Xerri
No Relationships to Disclose
 
Karin Tarte
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Epizyme (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Kite/Gilead; Roche
 
Delphine Pranger
No Relationships to Disclose